SCHEMBL21392901

SCHEMBL21392901

O=C(CCl)Nc1ccc(Oc2cccc(F)c2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RNF4 P78317 1/20 0.71
ALDH1A1 P00352 3/20 0.66
HTT P42858 3/20 0.66
MITF O75030 2/20 0.66
MAPK1 P28482 2/20 0.66
POLB P06746 1/20 0.66
MTNR1B P49286 7/20 0.54
MTNR1A P48039 5/20 0.54
SMN1; SMN2 Q16637 2/20 0.49
LMNA P02545 1/20 0.49
CYP1A2 P05177 1/20 0.49
GLA P06280 1/20 0.49
CYP3A4 P08684 1/20 0.49
MAPT P10636 1/20 0.49
CYP2C19 P33261 1/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
MAP2K7 O14733 2/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31703430 0.86 MTNR1B (0.54) RNF4ALDH1A1HTTMITFMAPK1
SCHEMBL31703396 0.84 RNF4 (0.73) RNF4ALDH1A1HTTMITFMAPK1
SCHEMBL8145133 0.84 MTNR1B (0.74) MTNR1BMTNR1A
SCHEMBL3382618 0.84 RNF4 (1.00) RNF4ALDH1A1HTTMITFMAPK1
SCHEMBL11806908 0.83 RNF4 (0.86) RNF4ALDH1A1HTTMITFMAPK1
SCHEMBL23748593 0.83 RNF4 (0.66) RNF4ALDH1A1HTTMITFMAPK1
SCHEMBL24075754 0.82 RNF4 (0.69) RNF4ALDH1A1HTTMITFMAPK1
SCHEMBL31703476 0.80 NR4A2 (0.60)
SCHEMBL23748677 0.80 RNF4 (0.75) RNF4ALDH1A1HTTMITFMAPK1
SCHEMBL31536277 0.80 RNF4 (0.75) RNF4ALDH1A1HTTMITFMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113164495-B Covalent targeting of E3 ligases 加利福尼亚大学董事会 2025-04-22 CN disclosed
US-20250120982-A1 COVALENT TARGETING OF E3 LIGASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2025-04-17 US disclosed
US-12161648-B2 Covalent targeting of E3 ligases THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-12-10 US disclosed
US-20210369731-A1 COVALENT TARGETING OF E3 LIGASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2021-12-02 US disclosed
US-20210369731-A1 COVALENT TARGETING OF E3 LIGASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2021-12-02 US disclosed
EP-3863642-A1 COVALENT TARGETING OF E3 LIGASES The Regents of the University of California (US) 2021-08-18 EP disclosed
CN-113164495-A Covalent targeting of E3 ligase 加利福尼亚大学董事会 2021-07-23 CN disclosed
US-20190290778-A1 METHODS AND COMPOUNDS FOR TARGETED AUTOPHAGY FRONTIER MEDICINES CORPORATION 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12161648-B2 Covalent targeting of E3 ligases RNF114, RNF4, RNF168 RNF4 2/4885ALDH1A1 2969/4885HTT 546/4885
US-20190290778-A1 METHODS AND COMPOUNDS FOR TARGETED AUTOPHAGY ATG7, BECN1, SQSTM1 RNF4 1274/4885ALDH1A1 4188/4885HTT 238/4885
US-20210369731-A1 COVALENT TARGETING OF E3 LIGASES RNF114, RNF4, RNF168 RNF4 2/4885ALDH1A1 2969/4885HTT 546/4885
US-20250120982-A1 COVALENT TARGETING OF E3 LIGASES STUB1, XIAP, RBX1 RNF4 13/4885ALDH1A1 2485/4885HTT 1558/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.